Syndax Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
Syndax Pharmaceuticals, Inc. (SNDX) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-08-04
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-06-30 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-03-31 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-12-31 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was $0.00.
- Syndax Pharmaceuticals, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 36 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 derived: sum of 3 quarters · filed 2025-11-03 | $0.00 10-K · filed 2025-03-03 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 4 quarters · filed 2025-11-03 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | $0.00 10-Q · filed 2025-08-04 | $0.00 derived: sum of 3 quarters · filed 2025-08-04 | $0.00 derived: sum of 4 quarters · filed 2025-08-04 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | $0.00 derived: sum of 2 quarters · filed 2025-05-05 | $0.00 derived: sum of 3 quarters · filed 2025-05-05 | $0.00 derived: sum of 4 quarters · filed 2025-05-05 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 derived: sum of 3 quarters · filed 2024-11-05 | $0.00 10-K · filed 2024-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | $0.00 derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-08-01 | $0.00 derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | $0.00 derived: sum of 3 quarters · filed 2024-05-08 | $0.00 derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 derived: sum of 3 quarters · filed 2023-11-02 | $0.00 10-K · filed 2023-02-28 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | ||||
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | ||||
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 | ||||
| 2019-12-31 | $0.00 10-K · filed 2020-03-05 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $0.00 10-K · filed 2019-03-07 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 derived: sum of 2 quarters · filed 2019-08-07 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |